Clinical Trial Update: High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes [NA]

View source ↗

Summary

The HIAMBA high-amylose barley trial for regulation and prevention of Type 2 Diabetes has completed. This entry notes completion but does not provide results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• High-amylose Barley (HIAMBA)

Snippet

Sponsor: University of Aarhus | Conditions: Type 2 Diabetes | NA | Status: COMPLETED